| Quinazoline pan-kras inhibitors |
2023-2-03 |
2023-8-10 |
|
| Sos1 inhibitors |
2022-11-29 |
2023-5-04 |
|
| 2-amino imidazole derivatives |
2022-11-04 |
2023-5-11 |
|
| Methods for separation of enantiomers |
2022-10-06 |
2023-4-13 |
|
| Combination therapies using prmt5 inhibitors for the treatment of cancer |
2022-10-06 |
2023-4-13 |
|
| Combination therapies of kras g12d inhibitors with sos1 inhibitors |
2022-10-04 |
2023-4-13 |
|
| Combinations of kras g12d inhibitors with irinotecan and related methods of … |
2022-10-04 |
2023-4-13 |
|
| Combination therapies of kras g12d inhibitors with shp-2 inhibitors |
2022-10-04 |
2023-4-13 |
|
| Combinations of kras g12d inhibitors with pi3ka inhibitors and related methods … |
2022-10-04 |
2023-4-13 |
|
| COMBINATION THERAPIES OF KRAS G12D INHIBITORS WITH Pan ErbB FAMILY INHIBITORS |
2022-10-04 |
2023-4-13 |
|
| MTA-Cooperative PRMT5 Inhibitors |
2022-9-12 |
2023-2-23 |
|
| Processes and intermediates for synthesis of adagrasib |
2022-9-08 |
2023-3-16 |
|
| SUBSTITUTED IMIDAZO[1,2-c]PYRIMIDINES AS PRC2 INHIBITORS |
2022-8-26 |
2023-5-04 |
|
| Kras g12d inhibitors |
2022-7-20 |
2023-3-09 |
|
| Aminopyridine-based mta-cooperative prmt5 inhibitors |
2022-6-29 |
2023-1-05 |
|
| Sos1 inhibitors |
2022-6-21 |
2022-12-29 |
|
| Combination therapies |
2022-5-27 |
2023-4-01 |
|
| Kras g12c inhibitors |
2022-4-14 |
2022-10-20 |
|
| Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer |
2022-4-05 |
2022-10-20 |
|
| Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer |
2022-4-05 |
2022-10-20 |
|
| Combination therapies |
2022-3-23 |
2022-5-01 |
|
| Mta-cooperative prmt5 inhibitors |
2022-3-11 |
2022-9-15 |
|
| Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, … |
2022-3-10 |
2022-9-15 |
|
| Combination therapies |
2022-1-28 |
2022-8-04 |
|
| Tetrahydropyridopyrimidine pan-kras inhibitors |
2021-12-16 |
2022-6-23 |
|
| Azaquinazoline pan-KRas inhibitors |
2021-12-15 |
2023-3-09 |
|
| Imidazo[1,2-c]pyrimidine derivatives as prc2 inhibitors for treating cancer |
2021-11-29 |
2022-1-01 |
|
| Kras g12d inhibitors |
2021-11-02 |
2022-5-12 |
|
| Methods for treatment of lung cancers |
2021-10-21 |
2023-8-30 |
|
| Kras g12d inhibitors |
2021-9-21 |
2023-8-02 |
|
| Combination therapies |
2021-9-15 |
2022-3-24 |
|
| Crystalline forms of a kras g12c inhibitor |
2021-9-10 |
2023-5-01 |
|
| Crystalline forms of a KRAS G12C inhibitor |
2021-9-10 |
2023-8-15 |
|
| Kras g12d inhibitors |
2021-8-03 |
2023-6-14 |
|
| Sos1 inhibitors |
2021-7-27 |
2022-2-03 |
|
| Combination therapies |
2021-3-25 |
2023-5-31 |
|
| Combination therapies |
2021-3-25 |
2022-6-29 |
|
| Kras g12d inhibitors |
2021-2-25 |
2023-9-07 |
|
| Kras g12d inhibitors |
2021-2-25 |
2022-1-20 |
|
| Sos1 inhibitors |
2021-2-23 |
2023-3-30 |
|
| SOS1 INHIBITORS |
2020-12-21 |
2022-3-23 |
|
| COMPOUNDS INHIBITORS OF PRMT5 MTA-COOPERATIVES |
2020-9-11 |
2022-1-26 |
|
| Crystal form of polytyrosine kinase inhibitor, preparation method and … |
2020-9-09 |
2022-4-26 |
|
| KRAS G12D INHIBITORS |
2020-8-27 |
2022-1-12 |
|
| Kras g12c inhibitors |
2020-6-30 |
2022-11-16 |
|
| Kras g12c inhibitors |
2020-6-12 |
2020-10-30 |
|
| Kras g12c inhibitors |
2020-5-07 |
2020-10-01 |
|
| Naphthyridine derivatives as prc2 inhibitors |
2020-4-21 |
2020-10-29 |
|
| Mat2a inhibitors |
2020-2-12 |
2020-8-20 |
|
| Combination therapies |
2019-9-10 |
2022-2-24 |
|
| Combination therapies |
2019-9-10 |
2022-2-10 |
|
| Combination therapies |
2019-9-09 |
2020-3-19 |
|
| Combination therapies |
2019-9-09 |
2022-2-10 |
|
| Kras g12c inhibitors |
2019-8-29 |
2021-7-29 |
|
| Kras g12c inhibitors |
2019-5-06 |
2019-11-14 |
|
| Hinged connector |
2019-1-25 |
2020-8-13 |
|
| Kras g12c inhibitors |
2018-11-07 |
2019-3-31 |
|
| Lsd1 inhibitors |
2018-6-22 |
2020-9-30 |
|
| EZH2 inhibitors |
2018-3-14 |
2019-4-23 |
2019-4-23 |
| Lsd1 inhibitors |
2016-11-03 |
2017-5-11 |
|
| Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors |
2013-7-19 |
2013-11-21 |
|
| Inhibitors of protein tyrosine kinase activity |
2013-2-14 |
2013-6-27 |
|
| Inhibitors of VEGF receptor and HGF receptor signaling |
2011-12-08 |
2012-12-11 |
2012-12-11 |